Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 341 | 503 | 1,060 | 7 | 84 |
| Inventories | 50 | 586 | 586 | 586 | 586 |
| Other current assets | 2 | 28 | 27 | 0 | 0 |
| TOTAL | $393 | $1,117 | $1,673 | $593 | $670 |
| Non-Current Assets | |||||
| PPE Net | 28 | 21 | 4 | 4 | 2 |
| Intangibles | 6 | 7 | 8 | 12 | 22 |
| Other Non-Current Assets | 284 | 297 | 308 | 0 | 0 |
| TOTAL | $317 | $324 | $319 | $16 | $24 |
| Total Assets | $710 | $1,441 | $1,993 | $609 | $694 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 647 | 685 | 621 | 578 | 519 |
| Accounts payable and accrued liabilities | 40 | 33 | 41 | 109 | 16 |
| Accrued Expenses | 1 | 44 | 65 | N/A | 60 |
| Other current liabilities | 0 | 29 | 1 | 2 | 1 |
| TOTAL | $734 | $830 | $754 | $689 | $595 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 241 | 253 | 262 | 0 | 0 |
| TOTAL | $241 | $253 | $262 | $N/A | $N/A |
| Total Liabilities | $975 | $1,083 | $1,015 | $689 | $595 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 932 | 932 | 917 | 917 | 881 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -4,266 | -3,039 | -2,373 | -1,723 | -1,261 |
| TOTAL | $-265 | $358 | $977 | $-80 | $99 |
| Total Liabilities And Equity | $710 | $1,441 | $1,993 | $609 | $694 |